Janux Has A License To Thrill With 007’s Prostate Cancer Results

 
• By Andrew McConaghie
  
Prostate cancer
CellCentric says it has a first-in-class prostate cancer therapy • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from Scrip